Total Payments
$744,976
2024 Payments
$4,250
Companies
9
Transactions
749
Payment Breakdown by Category
Other$456,134 (61.2%)
Consulting$174,654 (23.4%)
Travel$104,993 (14.1%)
Food & Beverage$9,196 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $452,949 | 188 | 60.8% |
| Consulting Fee | $174,654 | 70 | 23.4% |
| Travel and Lodging | $104,993 | 330 | 14.1% |
| Food and Beverage | $9,196 | 160 | 1.2% |
| Honoraria | $3,185 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Taiho Oncology, Inc. | $237,131 | 201 | $0 (2021) |
| Amgen Inc. | $224,188 | 299 | $0 (2019) |
| Lilly USA, LLC | $112,771 | 121 | $0 (2022) |
| Merck Sharp & Dohme LLC | $101,326 | 59 | $0 (2024) |
| Genentech USA, Inc. | $42,726 | 35 | $0 (2019) |
| Exelixis Inc. | $19,488 | 22 | $0 (2019) |
| Eli Lilly and Company | $5,089 | 7 | $0 (2017) |
| Halozyme Inc | $2,184 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $75.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,250 | 2 | Merck Sharp & Dohme LLC ($4,250) |
| 2023 | $9,990 | 4 | Merck Sharp & Dohme LLC ($9,990) |
| 2022 | $17,665 | 8 | Merck Sharp & Dohme LLC ($12,415) |
| 2021 | $10,758 | 6 | Merck Sharp & Dohme Corporation ($9,000) |
| 2020 | $26,552 | 21 | Merck Sharp & Dohme Corporation ($14,750) |
| 2019 | $157,704 | 185 | Amgen Inc. ($81,210) |
| 2018 | $276,239 | 273 | Taiho Oncology, Inc. ($116,246) |
| 2017 | $241,819 | 250 | Amgen Inc. ($106,188) |
All Payment Transactions
749 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Merck Sharp & Dohme LLC | LENVIMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2024 | Merck Sharp & Dohme LLC | LENVIMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,440.00 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $3,050.00 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2023 | Merck Sharp & Dohme LLC | LENVIMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $915.00 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2022 | Lilly USA, LLC | CYRAMZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Oncology | ||||||
| 07/26/2022 | Lilly USA, LLC | CYRAMZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: Oncology | ||||||
| 07/08/2022 | Merck Sharp & Dohme LLC | LENVIMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 01/05/2022 | Merck Sharp & Dohme LLC | LENVIMA (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2021 | Taiho Oncology, Inc. | Lonsurf (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,320.00 | General |
| Category: Oncology | ||||||
| 07/26/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2021 | Lilly USA, LLC | ERBITUX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $437.50 | General |
| Category: Oncology | ||||||
| 02/05/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2020 | Lilly USA, LLC | ERBITUX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $437.50 | General |
| Category: Oncology | ||||||
| 06/27/2020 | Taiho Oncology, Inc. | Lonsurf (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,565.00 | General |
| Category: Oncology | ||||||
About Dr. Daniel Haller, MD
Dr. Daniel Haller, MD is a Medical Oncology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639112949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Haller, MD has received a total of $744,976 in payments from pharmaceutical and medical device companies, with $4,250 received in 2024. These payments were reported across 749 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($452,949).
Ad
Practice Information
- Specialty Medical Oncology
- Location Philadelphia, PA
- Active Since 06/14/2006
- Last Updated 02/18/2011
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1639112949
Products in Payments
- Lonsurf (Drug) $237,131
- Vectibix (Biological) $223,749
- KEYTRUDA (Biological) $90,076
- ERBITUX (Drug) $57,739
- CYRAMZA (Drug) $48,788
- Avastin (Biological) $42,611
- Cabometyx (Drug) $19,488
- LENVIMA (Drug) $11,250
- ALIMTA (Drug) $1,166
- Kyprolis (Biological) $417.00
- IMFINZI (Drug) $75.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Philadelphia
Adam Cohen, Md, MD
Medical Oncology — Payments: $302,018
Medical Oncology $302,018
Dr. Jean-Pierre Issa, M.d, M.D
Medical Oncology — Payments: $223,097
Medical Oncology $223,097
Alexander Perl, Md, MD
Medical Oncology — Payments: $218,549
Medical Oncology $218,549
Carl June, Md, MD
Medical Oncology — Payments: $140,824
Medical Oncology $140,824
Anthony Olszanski, M.d, M.D
Medical Oncology — Payments: $131,641
Medical Oncology $131,641
Charalambos Andreadis, Md, MD
Medical Oncology — Payments: $126,184
Medical Oncology $126,184